Rheumatology

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA Alert
FDA Alert
FDA Alert
FDA Approves Rilzabrutinib Tablets for Chronic Immune Thrombocytopenia
09/10/2025
Kate Young
The FDA recently announced the approval of rilzabrutinib tablets for adults with persistent or chronic immune thrombocytopenia who did not respond to immunoglobulins, anti-D therapy, or corticosteroids. ...
09/10/2025
FDA ALERT
joint pain
FDA ALERT
FDA Approves First Biosimilar to Tocilizumab to Treat Adults, Pediatric Patients With Arthritis
11/15/2023
Jessica Ganga
In late September, the FDA approved the first biosimilar to tocilizumab to treat adult and pediatric patients with various indications of arthritis.
11/15/2023
pregnancy
pregnancy
FDA Warns Against NSAID Use During Second Half of Pregnancy
10/19/2020
Nonsteroidal anti-inflammatory drugs put the fetus at risk for rare but serious kidney complications.
10/19/2020
Arthritis
Arthritis
FDA Approves Treatment Option for Polyarticular Course JIA
10/01/2020
A Janus kinase inhibitor was approved for the treatment of active polyarticular course juvenile idiopathic arthritis among patients aged 2 years or older.
10/01/2020
FDA
FDA
FDA Approves Treatment Option for Polyarticular Course JIA
07/20/2020
The US Food and Drug Administration has approved tofacitinib for the treatment of active polyarticular course juvenile idiopathic arthritis among pediatric patients aged 2 years or older.
07/20/2020
Treatment
Treatment
FDA Approves New Option for Active Still Disease
06/17/2020
The drug was given priority review status by the FDA and was approved to treat adults with the rare, severe autoimmune disease.
06/17/2020
FDA
FDA
FDA Approves First Treatment for Pediatric SLE
04/29/2019
After the clinical trial showed positive results, the first treatment option for children with systemic lupus erythematosus has been approved.
04/29/2019
Rheumatology
Rheumatology
FDA Approves First Treatment for Certain Inflammatory Arthritis
03/28/2019
After the clinical trial showed positive results, the first treatment option for adults with inflammatory arthritis in the spine has been approved.
03/28/2019
Rheumatologic disorders
Rheumatologic disorders
FDA Approves New Biosimilar
10/31/2018
10/31/2018
Rheumatologic disorders
Rheumatologic disorders
FDA Approves Biosimilar to Humira
08/28/2017
The US Food and Drug Administration recently approved a biosimilar to Humira for the treatment of multiple inflammatory diseases in adult patients.
08/28/2017